🔗 Permalink

Inventor profile of:

Mitchell E. Reff

City:

San Diego, California

Country:

United States

Published Applications:

18

Last publication date:

2010-06-29

Top Assignees for applications by Mitchell E. Reff

The entities that hold a legal rights for patent applications filed by inventor Reff Mitchell E.:

BIOGEN IDEC INC. 9 Cambridge, MA United States
Biogen Idec MA Inc. 7 Cambridge, MA United States
IDEC Pharmaceuticals Corporation 1 San Diego, CA United States
Biogen Idec MA Inc. 1 San Diego, CA United States
BIOGEN IDEC INC. 1 San Diego, CA United States

Recent patent applications by Reff Mitchell E.

Mitchell E. Reff from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2010-06-29

US10238681

Expression and use of anti-CD20 Antibodies

#2 | 2009-03-12

US20090069553A1

Chemistry; metallurgy

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#3 | 2009-03-05

US20090061511A1

Chemistry; metallurgy

GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS

#4 | 2009-01-15

US20090018314A1

Chemistry; metallurgy

GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS

#5 | 2008-08-14

US20080193447A1

Chemistry; metallurgy

GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS

#6 | 2008-06-03

US9911692

Expression and use of anti-CD20 antibodies

#7 | 2008-04-17

US20080089893A9

Chemistry; metallurgy

Anti-CD20 antibodies

#8 | 2007-05-29

US10103686

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#9 | 2007-03-22

US20070065435A1

Chemistry; metallurgy

Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics

#10 | 2007-03-22

US20070065434A1

Chemistry; metallurgy

Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics

#11 | 2006-06-08

US20060121028A1

Chemistry; metallurgy

Variant IgG3 RITUXAN and therapeutic uses thereof

#12 | 2006-04-25

US9292053

γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#13 | 2006-04-06

US20060073147A1

Chemistry; metallurgy

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#14 | 2005-08-25

US20050186205A1

Chemistry; metallurgy

Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma

#15 | 2005-06-02

US20050118175A1

Chemistry; metallurgy

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#16 | 2005-05-19

US20050106222A1

Chemistry; metallurgy

Method to increase protein production in culture

#17 | 2005-05-17

US9019441

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

#18 | 2005-03-10

US20050054833A1

Chemistry; metallurgy

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

InventorID:

3858022 ⎘